消化管ステント市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、用途別、地域別、競合別、2020-2030年

消化管ステントの世界市場規模は、2024年に5億1,275万米ドルとなり、2030年までCAGR 5.38%を記録しながら安定的に成長すると予測されています。

消化管ステントは、食道、胃、腸、胆道などの消化管の開通を維持するために使用される重要な医療機器です。主に金属やプラスチックで構成されるこれらのステントは、がんや炎症、その他の消化管疾患による閉塞や狭窄に悩む患者に低侵襲の治療選択肢を提供します。市場は、技術的進歩や臨床応用の拡大とともに進化しており、市場力学の変化に適応するための業界各社の戦略的転換も進んでいます。例えば、2024年3月には、オリンパス株式会社が韓国のステントメーカーの買収計画から撤退し、世界の医療機器業界における戦略的重点の変化が示されました。

市場促進要因

胃腸疾患の有病率の上昇

主な市場課題

合併症のリスク

主な市場動向

生分解性ステント

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の消化管ステント市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（胆管ステント、結腸ステント、十二指腸ステント、食道ステント、膵臓ステント）
  • 用途別（胆道疾患、大腸がん、胃がん、炎症性腸疾患、その他）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • 製品タイプ別
  • 用途別
  • 地域別

第6章 北米の消化管ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の消化管ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域の消化管ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の消化管ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの消化管ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Boston Scientific Corporation
• Cook Group Inc
• Becton Dickinson & Co Ltd
• CONMED Corporation
• Cantel Medical LLC
• ELLA-CS, s.r.o.
• Hobbs Medical Inc.
• Merit Medical Systems, Inc.
• Olympus Corp
• Diagmed Healthcare Ltd

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Gastrointestinal Stents Market was valued at USD 512.75 million in 2024 and is projected to grow steadily, registering a CAGR of 5.38% through 2030. Gastrointestinal stents are vital medical devices used to maintain the patency of gastrointestinal pathways, including the esophagus, stomach, intestines, and biliary tract. Constructed primarily from metal or plastic, these stents offer minimally invasive treatment options for patients suffering from obstructions or strictures caused by cancer, inflammation, or other gastrointestinal disorders. The market is evolving with technological advancements and expanding clinical applications, alongside strategic shifts by industry players to adapt to changing market dynamics. For example, in March 2024, Olympus Corporation withdrew from its proposed acquisition of a South Korean stent manufacturer, signaling a shift in strategic focus within the global medical device landscape.

Key Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The growing global burden of gastrointestinal disorders is a major factor propelling demand for gastrointestinal stents. Conditions such as colorectal cancer, strictures, and functional gastrointestinal disorders (FGIDs) are increasingly common, leading to higher demand for effective interventions. According to the National Library of Medicine (2021), over 40% of the global population experiences FGIDs, significantly impacting patient well-being and placing greater strain on healthcare systems. This widespread prevalence underscores the need for accessible and effective solutions like stent placements to restore normal gastrointestinal function and alleviate symptoms.

Key Market Challenges

Risk of Complications

Despite their clinical utility, gastrointestinal stents come with inherent risks, including stent migration, perforation, and infections. These complications can compromise patient safety and require additional interventions, thus posing a challenge for clinicians. Achieving the optimal balance between therapeutic benefit and potential complications remains a critical consideration for healthcare professionals in stent selection and placement.

Key Market Trends

Biodegradable Stents

A notable trend gaining traction in the gastrointestinal stents market is the development and clinical adoption of biodegradable stents. Unlike traditional metal or plastic stents, biodegradable variants are designed to naturally degrade over time, eliminating the need for removal procedures. These stents reduce the risk of long-term complications and can minimize patient follow-up, offering a more patient-friendly and cost-effective alternative, particularly in temporary applications.

Key Market Players

• Boston Scientific Corporation
• Cook Group Inc
• Becton Dickinson & Co Ltd
• CONMED Corporation
• Cantel Medical LLC
• ELLA-CS, s.r.o.
• Hobbs Medical Inc.
• Merit Medical Systems, Inc.
• Olympus Corp
• Diagmed Healthcare Ltd

Report Scope:

In this report, the Global Gastrointestinal Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastrointestinal Stents Market, By Product Type:

• Biliary Stent
• Colonic Stent
• Duodenal Stent
• Esophageal Stent
• Pancreatic Stent

Gastrointestinal Stents Market, By Application:

• Biliary Disease
• Colorectal Cancer
• Stomach Cancer
• Inflammatory Bowel Disease
• Others

Gastrointestinal Stents Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gastrointestinal Stents Market.

Available Customizations:

Global Gastrointestinal Stents market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gastrointestinal Stents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 5.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product Type
  • 5.3.2. By Application
  • 5.3.3. By Region

6. North America Gastrointestinal Stents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 6.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gastrointestinal Stents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Gastrointestinal Stents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Gastrointestinal Stents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application

7. Europe Gastrointestinal Stents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 7.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gastrointestinal Stents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Gastrointestinal Stents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
  • 7.3.3. France Gastrointestinal Stents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Gastrointestinal Stents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Gastrointestinal Stents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Gastrointestinal Stents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 8.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Gastrointestinal Stents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
  • 8.3.2. Japan Gastrointestinal Stents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
  • 8.3.3. India Gastrointestinal Stents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Australia Gastrointestinal Stents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
  • 8.3.5. South Korea Gastrointestinal Stents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application

9. South America Gastrointestinal Stents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 9.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Gastrointestinal Stents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Gastrointestinal Stents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Gastrointestinal Stents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Gastrointestinal Stents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 10.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Gastrointestinal Stents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Gastrointestinal Stents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Gastrointestinal Stents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Boston Scientific Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Product Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Cook Group Inc
• 14.3. Becton Dickinson & Co Ltd
• 14.4. CONMED Corporation
• 14.5. Cantel Medical LLC
• 14.6. ELLA-CS, s.r.o.
• 14.7. Hobbs Medical Inc.
• 14.8. Merit Medical Systems, Inc.
• 14.9. Olympus Corp
• 14.10. Diagmed Healthcare Ltd

15. Strategic Recommendations

16. About Us & Disclaimer